IRIS
Lanzafame, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.585
AS - Asia 1.463
EU - Europa 1.125
Continente sconosciuto - Info sul continente non disponibili 377
SA - Sud America 351
AF - Africa 59
OC - Oceania 16
Totale 6.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.413
IT - Italia 666
SG - Singapore 458
VN - Vietnam 284
BR - Brasile 274
CN - Cina 274
KR - Corea 166
CA - Canada 87
FR - Francia 77
DE - Germania 74
NL - Olanda 65
GB - Regno Unito 61
BD - Bangladesh 49
FI - Finlandia 46
HK - Hong Kong 45
IN - India 43
MX - Messico 32
SE - Svezia 28
ZA - Sudafrica 27
AR - Argentina 23
PK - Pakistan 21
IQ - Iraq 20
RU - Federazione Russa 18
JP - Giappone 17
LV - Lettonia 17
EC - Ecuador 16
TR - Turchia 16
PL - Polonia 14
AU - Australia 13
ID - Indonesia 13
IE - Irlanda 11
JM - Giamaica 11
MA - Marocco 11
ES - Italia 10
SA - Arabia Saudita 10
CR - Costa Rica 9
TT - Trinidad e Tobago 9
VE - Venezuela 9
CO - Colombia 8
UA - Ucraina 8
AT - Austria 7
PE - Perù 7
PH - Filippine 7
JO - Giordania 6
EG - Egitto 5
IL - Israele 5
MY - Malesia 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
HN - Honduras 4
UY - Uruguay 4
UZ - Uzbekistan 4
AW - Aruba 3
CL - Cile 3
EE - Estonia 3
GT - Guatemala 3
KE - Kenya 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
AL - Albania 2
BF - Burkina Faso 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
MF - Saint Martin 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
Totale 6.593
Salva come PNG Salva come JPEG
Città #
Ashburn 430
San Jose 429
Council Bluffs 357
Dallas 322
Singapore 268
Seoul 165
Trento 131
Phoenix 101
Ho Chi Minh City 93
Los Angeles 84
Columbus 82
Chicago 66
Hanoi 58
New York 54
Beijing 51
Rome 51
Santa Clara 51
Milan 45
Lauterbourg 43
Hong Kong 41
Amsterdam 40
Helsinki 37
Munich 35
São Paulo 32
Buffalo 28
Orem 28
Secaucus 28
Boardman 27
Denver 27
Salt Lake City 24
Johannesburg 21
Riverside 21
St Louis 21
Atlanta 20
Montreal 20
Naples 20
Brooklyn 19
Cavalese 17
Da Nang 17
Houston 17
Riga 17
Mexico City 16
Levico Terme 15
North Bergen 15
Tokyo 15
Cornedo Vicentino 14
Jinan 14
London 13
Redondo Beach 13
Haiphong 12
Marcianise 12
Miami 12
Miano 12
Tampa 12
Warsaw 12
Brasília 11
Karachi 11
Mesa 11
Chennai 10
Manchester 10
San Francisco 10
Toronto 10
Charlotte 9
Elk Grove Village 9
Guangzhou 9
Padua 9
Philadelphia 9
Terrasini 9
Verona 9
Baghdad 8
Clifton 8
Frankfurt am Main 8
Mumbai 8
Rio de Janeiro 8
Ankara 7
Boston 7
Dublin 7
Las Vegas 7
Nuremberg 7
Paris 7
City of London 6
Detroit 6
Istanbul 6
Lahore 6
Lancaster 6
Newark 6
Pescara 6
Riyadh 6
Washington 6
Ziano di Fiemme 6
Baltimore 5
Belo Horizonte 5
Birmingham 5
Cairo 5
Canoas 5
Greenville 5
Hải Dương 5
Kansas City 5
Queens 5
Salvador 5
Totale 3.953
Salva come PNG Salva come JPEG
Nome #
Meningite da Escherichia Coli in una persona con infezione da HIV; descrizione di un caso clinico e revisione della letteratura = Escherichia Coli meningitis in a person living with HIV infection: a clinical case and review of the literature. 261
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol 172
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment 156
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure 117
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 112
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 110
Mini-review: Silico-tuberculosis 110
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study 106
Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion 106
Benign acute viral myositis in African migrants: a clinical, serological and pathological study 105
Breastfeeding in women living with HIV in high-income countries: It's time to act 103
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 102
Bridging the gap in bloodstream infection management: a survey among non-infectious disease physicians 102
Uso degli antibiotici nel fine vita 100
When an underestimated zoonosis and antimicrobial resistance collide: Corynebacterium ulcerans 96
Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States 94
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study 92
Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study 88
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment. 87
Recurrent UTI: Questions and Answers on Clinical Practice 86
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience 84
Primary cutaneous cryptococcosis in a HIV infested patient: case report 82
Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report 78
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 75
"High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART 72
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy) 72
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study 72
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer 71
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 70
“Terapia intermittente” con bictegravir/emtricitabina/tenofovir alafenamide in una piccola coorte di pazienti con infezione da HIV, virologicamente soppressi = Short cycle therapy with bictegravir/emtricitabine/tenofovir alafenamide in a small cohort of virally suppressed people living with HIV. 67
Klebsiella pneumoniae resistant to carbapenems: bloodstream infection prevalence before and during the SARS-CoV-2 pandemic in a tertiary level, North-Eastern Italian Hospital 66
Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities 66
High malaria parasitemia in an Italian man and severe delayed hemolytic anemia 63
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 63
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs―Experience From Northern Italy 62
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 62
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? 62
. Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics 61
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report 61
Adherence to HAART in HIV 59
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection 56
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 55
Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up 54
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 54
Community acquired bacteremia In older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study 54
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy 53
Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study 52
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab 51
The burden and epidemiology of community-acquired central nervous system infections: a multinational study 50
HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study 49
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients 49
Features of Mpox infection: The analysis of the data submitted to the ID-IRI network 48
Influenza dell’attività fisica sul valore ematico dei lipidi in una piccola coorte di pazienti che vivono con infezione da HIV, soppressi e dislipidemici, dopo lo switch da un regime contenente tenofovir alafenamide a dolutegravir/rilpivirina = Influence of physical activity level on serum lipid values in a small cohort of suppressed dyslipidemic people living with HIV after switching from a tenofovir alafenamide regimen to dolutegravir/rilpivirine. 47
Factors affecting inflammatory markers in neutropenic patients with bacteremia: An international ID-IRI study 47
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 47
Antiretroviral therapy-associated diseases are common in the long-term 46
A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients 46
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 46
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice. 45
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 44
HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa 44
HIV-1 RNA levels in semen of people on 'short-cycle' antiretroviral therapy 42
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients 42
Antiretroviral therapy in low-resource settings 42
Socio-demographic Characteristics, Sexual and Test-Seeking Behaviours Amongst Men Who have Sex with Both Men and Women: Results from a Bio-behavioural Survey in 13 European Cities 41
Aetiology of pneumonia following isolated closed head iniury 41
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 41
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation 41
Patient-centered Care and Treatment in HIV Infection 40
HIV treatment default in sub-Saharan Africa: issues and possible solutions 40
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 40
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 40
Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients 40
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 39
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 37
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 37
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study) 36
The treatment of latent TB infection in HIV-positive people: the Verona experience 36
La riduzione del dosaggio giornaliero di efavirenz nella terapia antiretrovirale: impatto sul budget nell’Azienda Ospedaliera Universitaria Integrata di Verona 35
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV 34
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 33
Tuberculosis-immune reconstitution inflammatory syndrome 33
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug 30
Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA? 30
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 30
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 30
HIV infection should no longer be detected at late stages in Italy 30
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 30
Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature 29
Hyperacute unilateral gonococcal endophtalmitis in an HIV-infected man without genital infection 27
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium Falciparum malaria 26
Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery 26
Optimal fosamprenavir regimen to prevent lipid abnormalities. 25
Delayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease 25
Efavirenz dose reduction in HIV-infected patients 25
Chagas disease in Italy: breaking an epidemiological silence 25
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 25
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinico 24
Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient 24
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 24
Totale 6.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025302 0 0 0 0 0 0 0 0 1 179 34 88
2025/20264.469 113 157 585 599 621 274 322 220 517 679 190 192
2026/20272.205 248 345 613 999 0 0 0 0 0 0 0 0
Totale 6.976